PODXL is upregulated in several types of cancer, and strong expression, in particular in the cell membrane, has been demonstrated to signify more aggressive tumours and poor prognosis in e.g. breast cancer [13], colorectal cancer [14-17] ovarian cancer [18], urinary bladder cancer [19], and glioblastoma [20]. Here, PODXL is linked to urinary bladder cancer.